Hedgehog Related Protein Expression in Breast Cancer: Gli-2 Is Associated with Poor Overall Survival.
- Author:
Soyoung IM
1
;
Hyun Joo CHOI
;
Changyoung YOO
;
Ji Han JUNG
;
Ye Won JEON
;
Young Jin SUH
;
Chang Suk KANG
Author Information
1. Department of Hospital Pathology, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea. chj0103@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Hedgehog proteins;
Gli-2 protein;
Gli protein;
Breast neoplasms
- MeSH:
Breast;
Breast Neoplasms;
Hedgehog Proteins;
Hedgehogs;
Humans;
Lymph Nodes;
Neoplasm Metastasis;
Oncogene Proteins;
Oncogenes;
Phenotype;
Proteins;
Survival Rate;
Trans-Activators
- From:Korean Journal of Pathology
2013;47(2):116-123
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The hedgehog (Hh) signaling pathway is known to play a critical role in various malignancies, but its clinicopathologic role in breast cancer is yet to be established. METHODS: Tissue microarray blocks from 334 cases of breast cancer were prepared. The expression of six Hh signaling proteins including sonic hedgehog (Shh), patched (Ptch), smoothened (Smo), and the glioma-associated oncogene (Gli)-1, Gli-2, and Gli-3 were analyzed immunohistochemically. RESULTS: The expression of Hh signaling proteins was significantly correlated with some prognostic factors including the correlation of lymph node metastasis with the expression of Shh (p=0.001) and Ptch (p=0.064), the correlation of the stages with Shh and Gli-3 expression (p=0.007 and p=0.024, respectively), the correlation of the nuclear grade with the Smo (p=0.004) and Gli-3 (p=0.000), and the correlation of the histologic grade with the Ptch (p=0.016), Smo (p=0.007), and Gli-3 (p=0.000). The Shh, Ptch, Smo, Gli-1, and Gli-2 expression was significantly different between the phenotypes (p=0.000, p=0.001, p=0.004, p=0.039, and p=0.031, respectively). Gli-2 expression was correlated with a worse overall survival outcome (p=0.012). CONCLUSIONS: Hh pathway activation is correlated with a more aggressive clinical behavior in breast carcinomas. The comparison of phenotypes suggested that the Hh pathway may be a useful therapeutic target for breast carcinoma. Patients with Gli-2 expression had a significantly lower overall survival rate and, therefore, it showed promise as a prognostic marker.
